Incyte sec filings
WebSEC Filings Incyte Corp (INCY) 10-K Annual Report Tue Feb 07 2024 10-Q Quarterly Report May 2024 10-Q Quarterly Report November 2024 10-Q Quarterly Report August 2024 10-Q … WebOct 25, 2024 · Incyte gains exclusive, worldwide development and commercialization rights to MGA012 in all indications; ... the availability or commercial potential of MacroGenics' product candidates and other risks described in MacroGenics' filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press ...
Incyte sec filings
Did you know?
WebApr 12, 2024 · Ballentine Partners LLC acquired a new position in shares of Incyte Co. (NASDAQ:INCY – Get Rating) in the 4th quarter, according to its most recent Form 13F … WebApr 9, 2024 · Dupont Capital Management Corp lifted its position in shares of Incyte Co. (NASDAQ:INCY - Get Rating) by 215.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission.The institutional investor owned 9,032 shares of the biopharmaceutical company's stock after …
WebApr 11, 2024 · Exchange Traded Concepts LLC decreased its position in Incyte Co. (NASDAQ:INCY - Get Rating) by 7.5% during the 4th quarter, according to the company in … WebApr 12, 2024 · Ballentine Partners LLC acquired a new position in shares of Incyte Co. ( NASDAQ:INCY - Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,609 shares of the biopharmaceutical company's stock, valued at approximately $210,000. 3 S&P 500 …
WebJan 9, 2024 · WILMINGTON, D.E. & KENILWORTH, N.J. – Incyte Corporation (Nasdaq:INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the decision to advance the clinical development program investigating the combination of epacadostat, Incyte’s investigational oral selective IDO1 inhibitor, with … WebSep 27, 2024 · The companies will share development costs associated with global and U.S. -specific trials for all agreed upon trials at a rate of 55% ( Incyte) and 45% (Syndax), with Incyte responsible for 100% of future development costs for trials that are specific to ex- …
WebIncyte Corp. SEC filings breakout by MarketWatch. View the INCY U.S. Securities and Exchange Commission reporting information. Skip to main contentMain Menu Home …
WebApr 6, 2024 · Incyte Corp. – Filings and Transcripts – BamSEC Incyte Corp. Watch NASDAQ: INCY Share price (3/29/23): $71.14 Market cap (3/29/23): $15.9 billion 8 Incyte Corp. Expert Interviews, now on BamSEC. Powered by Tegus. See All INCY Interviews Financials Filter 10-K ended 12/31/22 FY 2024 02/07/23 10-Q ended 09/30/22 Q3 11/01/22 10-Q ended … react app with login githubWebApr 15, 2024 · International Biotechnology Trust PLC lowered its stake in Incyte Co. (NASDAQ:INCY - Get Rating) by 20.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 229,000 shares of the biopharmaceutical company's stock after selling 60,000 shares during the period. Incyt how to start an autobiography essay exampleWebApr 15, 2024 · Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.34% of Incyte worth $59,867,000 as of its most recent filing with the Securities and Exchange … react app.use is not a functionWebApr 11, 2024 · Strs Ohio’s holdings in Incyte were worth $2,095,000 as of its most recent SEC filing. Several other hedge funds and other institutional investors have also recently made changes to their ... react app with azure ad authenticationWebApr 5, 2024 · INCY traded up $1.14 on Wednesday, hitting $73.79. 266,480 shares of the company's stock were exchanged, compared to its average volume of 1,653,264. The company has a current ratio of 3.54, a quick ratio of 3.50 and a debt-to-equity ratio of 0.01. The stock has a fifty day moving average of $77.16 and a two-hundred day moving … how to start an award programWebApr 11, 2024 · Exchange Traded Concepts LLC decreased its position in Incyte Co. (NASDAQ:INCY - Get Rating) by 7.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 25,291 shares of the biopharmaceutical company's stock after selling 2,039 shares during the q how to start an automotive machine shopWebApr 9, 2024 · The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Incyte news, EVP … how to start an automotive shop